期刊文献+

NT-proBNP、hs-CRP和超声心动图与急性冠状动脉综合征病变程度的相关性研究 被引量:25

NT-proBNP,hs-CRP and echocardiography:predictive value for the degree of coronary artery lesion
下载PDF
导出
摘要 目的探讨血浆NT-proBNP、hs-CRP水平和彩色多普勒超声心动图与急性冠状动脉综合征(ACS)早期缺血坏死及冠状动脉病变严重程度的相关性。方法选择2013年3月至2014年2月因胸痛入住该院的患者,采集病史,所有患者入院24h内测定血浆NT-proBNP、hs-CRP和cTnT水平,记录超声心动图左室射血分数(LVEF)值和右室舒张末内径(LVEDd)值,且住院期间行冠状动脉造影确诊。根据病史、心电图、冠状动脉造影、cTnT结果分为ST段抬高型心肌梗死(STEMI)组、非ST段抬高型心肌梗死(NSTEMI)组、不稳定型心绞痛(UA)组及对照组。冠状动脉病病变严重程度根据冠状动脉造影结果分为单支病变组、双支病变组、三支病变组和阴性对照组。分析血浆NT-proBNP、hs-CRP水平及LVEF值在各组间的差异,多因素线性回归分析判断其是否为血浆NT-proBNP的独立性危险因素。结果入组ACS患者共102例。对照组(n=40)、UA组(n=40)分别与NSTEMI组(n=30)、STEMI组(n=32)比较,患者血浆NT-proBNP、hs-CRP水平及LVEF值差异均有统计学意义(P<0.05)。阴性对照组(n=40)和三支病变组(n=41)分别与单支病变组(n=30)、双支病变组(n=31)比较,血浆NT-proBNP水平差有统计学意义异(P<0.05)。多因素线性回归分析示:血浆hs-CRP水平(P=0.007)、冠状动脉病变支数(P=0.001)、糖尿病病史(P=0.006)均为血NT-proBNP水平的独立正相关因素,LVEF值(P=0.036)则为血NT-proBNP水平的独立负相关因素。结论血浆NT-proBNP、hs-CRP水平、LVEF值与ACS关系密切,可作为判断其早期缺血坏死程度和临床分型的重要参考指标。血浆NT-proBNP水平有可能作为一种判断冠状动脉病变严重程度的分子标志物。 Objective To investigate the correlation between NT-proBNP,hs-CRP level.echoeardiography and early avascular necrosis of coronary artery syndrome (ACS) ,coronary artery lesion degree. Methods 142 patients admitted in this hospital for chest pain from March 2013 to February 2014 were enrolled, and all patients' history, electrocardiogram (ECG), plasma levels of N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) ,hypersensitive C-reative protein (hs-CRP) and eTnT were recorded or tested within 24 hours,while left ventricular ejection fraction (LVEF) and left ventricular end-diastolic diameter (LVEDd) were recorded by echocardiography. According to the history and coronary angiography results conducted during hospitalization, patients were divided into acute ST segment elevation myocardial infarction (STEMI) group,acute non-ST segment elevation myocardial infarction (NSTEMI) group, unstable angina pectoris (UA) group and control group (normal coronary angiography, cTnT and ECG). Patients with abnormal coronary angiography results were further divided into single vessel lesion group, double vessel lesion group and triple vessel lesion group. The differences of plasma NT-proBNP level, hs-CRP level and LVEF in each group, and multivariate linear regression analysis were conducted to find out the independent risk factors for elevated plasma NT-proBNP. Results 102 ACS patients and 40 normal patients were enrolled. Plasma levels of NT-proBNP, hs-CRP and LVEF in NSTEMI group (n = 30) and STEMI group (n= 32) were significant different from UA group (n = 40) and control group (n= 40) respectively (P〈0.05). The NT-proBNP levels in control group and triple vessel lesion group (n=41) were respectively significant different from both single vessel lesion group (n:30) and double vessel lesion group (n=31) (P〈0.05). Multivariate linear regression analysis showed that, plasma hs-CRP level (P= 0. 007), coronary artery lesion degree (P = 0.00) and history of diabetes (P = 0. 006) were positive associated factors of NT-proBNP level, while LVEF was the negative associated factors of NT-proBNP level(P= 0. 036). Conclusion Plasma NT-proBNP level, hs-CRP level and LVEF are closely related to ACS,and they might play an important rote in determining the extent of early ischemic necrosis and clinical classification. Plasma NT-proBNP level could be an important molecular mark- er to reflect the degree of coronary artery lesion.
作者 陈丰运 肖骅
出处 《重庆医学》 CAS 北大核心 2015年第31期4338-4342,共5页 Chongqing medicine
基金 国家自然科学基金资助项目(81300140) 重庆市自然科研基金资助项目(CSTC 2009BB5405) 国家临床重点专科建设项目经费资助(财社[2011]170号)
关键词 急性冠脉综合征 氨基末端脑钠肽前体 高敏C反应蛋白 左室射血分数 冠状动脉病变程度 acute coronary syndrome natriuretic peptide,brain C-reative protein cardiac output degress of coronary arterial stenosis
  • 相关文献

参考文献21

  • 1Kramer MC, Rittersma SZ,De Winter RJ, et al. Relation-ship of thrombus healing to underlying plaque morphologyin sudden coronary death[J]. J Am Coll Cardiol,2010,55(2):122-132.
  • 2Go AS,Mozaffarian D,Roger VL,et al. Executive summa-ry: heart disease and stroke statistics-2014 update: a re-port from the American Heart Association [J]. Circula-tion,2014,129(3) :399-410.
  • 3Toth M, Vuorinen KH. Vuolteenaho O,et al. Hypoxiastimulates release of ANP and BNP from perfused ratventricular myocardium[J]. Am J Physiol.1994.266(4 Pt2):H1572-1580.
  • 4Struthers AD,Davies J. B-type natriuretic peptide: a sim-pie new test to identify coronary artery disease. [J].QJM,2005,98(10):765-769.
  • 5Keskin O, Ulusoy RE, Kalemoglu M, et al. White bloodcell count and C-reactive protein predict short-term prog-nosis in acute myocardial infarction[J]. J Int Med Res,2004,32(6):646-654.
  • 6Weidemann F,Niemann M,Herrmann S,et al. Assess-ment of diastolic heart failure. Current role of echocardio-graphy[J], Herz,2013 ,38(1) : 18-25.
  • 7Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the managementof patients with unstable angina/Non-ST-Elevation myo-cardial infarction (updating the 2007 guideline and repla-cing the 2011 focused update) a report of the Americancollege of cardiology foundation/American heart associa-tion task force on practice guidelines developed in collabo-ration with the American college of emergency physi-cians, society for cardiovascular angiography and inter-ventions . and society of thoracic surgeons[J]. Circulation,2012,126(7):875.
  • 8陈丰运,肖骅.脑钠肽在非心力衰竭疾病中的研究进展[J].重庆医学,2013,42(30):3689-3692. 被引量:9
  • 9Mockel M, Danne O, Muller R, et al. Development of anoptimized multimarker strategy for early risk assessmentof patients with acute coronary syndromes[J]. Clin ChimActa,2008,393(2) :103-109.
  • 10Qin YW, Teng X, He JQ, et al. Increased plasma levels of intermedin and brain natriuretic peptide associated with severity o{ coronary stenosis in acute coronary syndrome [J]. Peptides,2013,42:84-88.

二级参考文献48

  • 1蒋作锋,韦建瑞,余慧文,郭顺华,张锐,张文超,陈辉,黄丽萍,郭衡山.原发性高血压患者N端脑钠肽前体测定及其意义[J].岭南心血管病杂志,2005,11(6):383-385. 被引量:4
  • 2李冬,焦连亭.脑钠素与肾损伤[J].国际检验医学杂志,2006,27(12):1094-1096. 被引量:10
  • 3Eggers KM, Lagerqvist B, Venge P. Prognostic value ofbiomarkers during and after non-ST-segment elevation a-cute coronary syndrome [ J]. Am Coll Cardiol,2009,54(4):357-364.
  • 4Ogawa A,Seino Y, Yamashita T,et al. Difference in eleva-tion of N-terminal pro-BNP and conventional cardiacmarkers between patients with ST elevation vs non-ST el-evation acute coronary syndrome[J].Circ J,2006,70(11) :1372-1378.
  • 5Asada J,Tsuji H, Iwasaka T, et al. Usefulness of plasmabrain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia [J]. Am J Cardiol,2004,93(6):702-704.
  • 6Mayer O Jr,Simon J, Plaskova M. N-terminal pro B-typenatriuretic peptide as prognostic marker for mortality incoronary patients without clinically manifest heart failure[J]. Eur Epidemiol, 2009 ,24(7) : 363-368.
  • 7Palazzuoli A, Rizzello V, Calabro A Osteoprotegerin andB-type natriuretic peptide in non-ST elevation acute coro-nary syndromes : relation to coronary artery narrowing andplaques number[J]. Clin Chim Acta,2008,391 (12) : 74-79.
  • 8Dominguez-Rodriguez A, Areu-Gonzalez P, Avanzas P,Avanazas P, et al. Neopterin predicts left ventricular re-modeling in patients with ST-segment elevation myocar-dial infarction undergoing primary percutanenous coro-nary intervention]]J]. Atherosclerosis,2010,211(2):574-578.
  • 9Steen H,Futterer S,Merten C,et al. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estima-tion of infarct size and left ventricular function after acutemyocardial infarction[J], J Cardiovasc Magn Reson,2007,9(5):749-758.
  • 10Giannitsis E,Kurz K,Hallermayer K,et al. Analytical val-idation of a high-sensitivity cardiac troponin T assay [J].Clin Chem,2010,56(2) :254-261.

共引文献21

同被引文献220

引证文献25

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部